Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raiees Andrabi

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Immunity|November 21, 2015
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine DesignRaiees Andrabi, James E Voss, Chi-Hui Liang, et al.
Plos One|May 12, 2015
Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian IndividualLubina Khan, Muzamil Ashraf Makhdoomi, Sanjeev Kumar, et al.
Immunity|September 17, 2017
Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody DevelopmentRaiees Andrabi, Ching-Yao Su, Chi-Hui Liang, et al.
Nature Communications|April 10, 2023
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spikeTimothy J C Tan, Zongjun Mou, Ruipeng Lei, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2022
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spikeTimothy J C Tan, Zongjun Mou, Ruipeng Lei, et al.
Mbio|July 4, 2019
Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV<sub>smm/mac</sub> Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from NeutralizationBenjamin von Bredow, Raiees Andrabi, Michael Grunst, et al.
Virology|March 8, 2013
Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individualsRaiees Andrabi, Constance Williams, Xiao-Hong Wang, et al.
Iscience|March 29, 2024
High affinity mAb infusion can enhance maximum affinity maturation during HIV Env immunizationPeter Thomas, Chloe Rees-Spear, Sarah Griffith, et al.
Nature Communications|May 12, 2023
Evolution of antibody immunity following Omicron BA.1 breakthrough infectionChengzi I Kaku, Tyler N Starr, Panpan Zhou, et al.
AIDS (London, England)|July 19, 2016
Reproducing SIVΔnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front linesJames E Voss, Matthew S Macauley, Kenneth A Rogers, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Immunity|November 21, 2015
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine DesignRaiees Andrabi, James E Voss, Chi-Hui Liang, et al.
Plos One|May 12, 2015
Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian IndividualLubina Khan, Muzamil Ashraf Makhdoomi, Sanjeev Kumar, et al.
Immunity|September 17, 2017
Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody DevelopmentRaiees Andrabi, Ching-Yao Su, Chi-Hui Liang, et al.
Nature Communications|April 10, 2023
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spikeTimothy J C Tan, Zongjun Mou, Ruipeng Lei, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2022
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spikeTimothy J C Tan, Zongjun Mou, Ruipeng Lei, et al.
Mbio|July 4, 2019
Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV<sub>smm/mac</sub> Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from NeutralizationBenjamin von Bredow, Raiees Andrabi, Michael Grunst, et al.
Virology|March 8, 2013
Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individualsRaiees Andrabi, Constance Williams, Xiao-Hong Wang, et al.
Iscience|March 29, 2024
High affinity mAb infusion can enhance maximum affinity maturation during HIV Env immunizationPeter Thomas, Chloe Rees-Spear, Sarah Griffith, et al.
Nature Communications|May 12, 2023
Evolution of antibody immunity following Omicron BA.1 breakthrough infectionChengzi I Kaku, Tyler N Starr, Panpan Zhou, et al.
AIDS (London, England)|July 19, 2016
Reproducing SIVΔnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front linesJames E Voss, Matthew S Macauley, Kenneth A Rogers, et al.
Pageof 10